Karlan BY - Search Results

1

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

2

Secreted ovarian stromal substance inhibits ovarian epithelial cell proliferation.

Karlan BY, Baldwin RL, Cirisano FD, Mamula PW, Jones J, Lagasse LD. Karlan BY, et al. Gynecol Oncol. 1995 Oct;59(1):67-74. doi: 10.1006/gyno.1995.1269. Gynecol Oncol. 1995. PMID: 7557618

3

Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines.

Jones J, Lagasse LD, Karlan BY. Jones J, et al. Among authors: karlan by. Gynecol Oncol. 1994 Dec;55(3 Pt 1):421-6. doi: 10.1006/gyno.1994.1316. Gynecol Oncol. 1994. PMID: 7835782

4

Perioperative coagulopathy in patients undergoing primary cytoreduction.

Brown JV, Karlan BY, Greenspoon JS, Rosove MH, Lagasse LD. Brown JV, et al. Among authors: karlan by. Cancer. 1993 Apr 15;71(8):2557-61. doi: 10.1002/1097-0142(19930415)71:8<2557::aid-cncr2820710820>3.0.co;2-3. Cancer. 1993. PMID: 8453579

5

Ovarian cancer screening. The role of ultrasound in early detection.

Karlan BY, Platt LD. Karlan BY, et al. Cancer. 1995 Nov 15;76(10 Suppl):2011-5. doi: 10.1002/1097-0142(19951115)76:10+<2011::aid-cncr2820761318>3.0.co;2-l. Cancer. 1995. PMID: 8634993 Review.

6

High-throughput plasmid mini preparations facilitated by micro-mixing.

Ng WL, Schummer M, Cirisano FD, Baldwin RL, Karlan BY, Hood L. Ng WL, et al. Among authors: karlan by. Nucleic Acids Res. 1996 Dec 15;24(24):5045-7. doi: 10.1093/nar/24.24.5045. Nucleic Acids Res. 1996. PMID: 9016678 Free PMC article.

7

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.

Abrahamson J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D, Ben David Y, Biran H, Fields A, Brunet JS, Narod SA. Abrahamson J, et al. Cancer Res. 1998 Jul 15;58(14):2919-22. Cancer Res. 1998. PMID: 9679945

8

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.

Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY. Bristow RE, et al. Among authors: karlan by. Cancer. 1999 Feb 1;85(3):658-68. doi: 10.1002/(sici)1097-0142(19990201)85:3<658::aid-cncr16>3.0.co;2-m. Cancer. 1999. PMID: 10091739

9

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.

Karlan BY, Baldwin RL, Lopez-Luevanos E, Raffel LJ, Barbuto D, Narod S, Platt LD. Karlan BY, et al. Am J Obstet Gynecol. 1999 Apr;180(4):917-28. doi: 10.1016/s0002-9378(99)70663-0. Am J Obstet Gynecol. 1999. PMID: 10203660

10

Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis.

Baldwin RL, Tran H, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Gynecol Oncol. 1999 Aug;74(2):265-71. doi: 10.1006/gyno.1999.5448. Gynecol Oncol. 1999. PMID: 10419743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters